Talquetamab,Teclistamab,Daratumumab
Genmab,Janssen
['multiplemyeloma', 'redirectt-1', 'janssen']
for us #hcps at #asco23, tune in to dr. yael cohen as she presents first results from the phase 1b/2 redirectt-1 study evaluating a dual combination of bcma and gprc5d bispecific antibodies in patients with relapsed/refractory #multiplemyeloma. 
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.